These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9802350)

  • 1. Sensitivity and specificity of antibodies on necrotic tumor tissue.
    Judkins AR; Montone KT; LiVolsi VA; van de Rijn M
    Am J Clin Pathol; 1998 Nov; 110(5):641-6. PubMed ID: 9802350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of immunohistochemistry in the evaluation of necrotic thyroid tumors.
    Judkins AR; Roberts SA; Livolsi VA
    Hum Pathol; 1999 Nov; 30(11):1373-6. PubMed ID: 10571520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
    Devaney K; Vinh TN; Sweet DE
    Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin positivity in fine-needle aspirates of melanomas and sarcomas.
    Banks ER; Jansen JF; Oberle E; Davey DD
    Diagn Cytopathol; 1995 May; 12(3):230-3. PubMed ID: 7542582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical criteria in the differential diagnosis of malignant melanoma versus carcinoma, lymphoma and sarcoma in fine needle aspirates.
    Domagała W; Chosia M; Bedner E; Weber K; Osborn M
    Patol Pol; 1991; 42(3):73-8. PubMed ID: 1845482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel cell) carcinoma of the skin, lymphoma, and oat cell carcinoma.
    Battifora H; Silva EG
    Cancer; 1986 Sep; 58(5):1040-6. PubMed ID: 2425928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of demonstration of cytokeratin and leukocyte common antigen in poorly differentiated malignant tumors in fine needle aspirates.
    Rajasekhar A; Kapila K; Verma K
    Acta Cytol; 1989; 33(3):385-9. PubMed ID: 2471381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of necrotic malignant melanomas.
    Nonaka D; Laser J; Tucker R; Melamed J
    Am J Clin Pathol; 2007 May; 127(5):787-91. PubMed ID: 17439838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
    Conner JR; Cibas ES; Hornick JL; Qian X
    Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of microscopic findings and immunohistochemistry in the classification of necrotic testicular tumors: a study of 11 cases.
    Miller JS; Lee TK; Epstein JI; Ulbright TM
    Am J Surg Pathol; 2009 Sep; 33(9):1293-8. PubMed ID: 19461507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100 protein immunoreactivity in poorly differentiated carcinomas. Immunohistochemical comparison with malignant melanoma.
    Drier JK; Swanson PE; Cherwitz DL; Wick MR
    Arch Pathol Lab Med; 1987 May; 111(5):447-52. PubMed ID: 2436593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
    Buonaccorsi JN; Plaza JA
    Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemistry in the diagnosis of sarcomas].
    Decouvelaere AV
    Ann Pathol; 2012 Nov; 32(5 Suppl):S101-2. PubMed ID: 23127922
    [No Abstract]   [Full Text] [Related]  

  • 14. A panel of antibodies useful in the cytologic diagnosis of metastatic melanoma.
    Shoup SA; Johnston WW; Siegler HF; Tello JW; Schlom J; Bigner DD; Bigner SH
    Acta Cytol; 1990; 34(3):385-92. PubMed ID: 1693028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of epithelial marker expression in routinely processed, poorly differentiated carcinomas.
    Kamel OW; Rouse RV; Warnke RA
    Arch Pathol Lab Med; 1991 Jun; 115(6):566-70. PubMed ID: 1710100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing tumours on routine surgical sections by immunohistochemistry: use of cytokeratin, common leucocyte, and other markers.
    Poston RN; Sidhu YS
    J Clin Pathol; 1986 May; 39(5):514-23. PubMed ID: 2424934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical study of tissues from clinically normal dogs and of neoplasms, using keratin monoclonal antibodies.
    Sandusky GE; Wightman KA; Carlton WW
    Am J Vet Res; 1991 Apr; 52(4):613-8. PubMed ID: 1711298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric large cell lymphoma expressing cytokeratin but no leukocyte common antigen. A diagnostic dilemma.
    de Mascarel A; Merlio JP; Coindre JM; Goussot JF; Broustet A
    Am J Clin Pathol; 1989 Apr; 91(4):478-81. PubMed ID: 2467551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-alpha 1-antichymotrypsin staining of 194 sarcomas, 38 carcinomas, and 17 malignant melanomas. Its lack of specificity as a tumour marker.
    Leader M; Patel J; Collins M; Henry K
    Am J Surg Pathol; 1987 Feb; 11(2):133-9. PubMed ID: 2433954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.